7 results on '"Rivero-Calle I"'
Search Results
2. Incidence and risk factor prevalence of community-acquired pneumonia in adults in primary care in Spain (NEUMO-ES-RISK project).
- Author
-
Rivero-Calle, I., Pardo-Seco, J., Aldaz, P., Vargas, D. A., Mascarós, E., Redondo, E., Díaz-Maroto, J. L., Linares-Rufo, M., Fierro-Alacio, M. J., Gil, A., Molina, J., Ocaña, D., and Martinón-Torres, Federico
- Subjects
- *
COMMUNITY-acquired pneumonia , *DISEASE prevalence , *PUBLIC health , *DISEASE risk factors - Abstract
Background: Community-acquired pneumonia (CAP) is a major cause of morbidity and mortality in adults even in developed countries. Several lifestyle factors and comorbidities have been linked to an increased risk, although their prevalence has not been well documented in the primary care setting. The aim of this study is to assess the incidence, risk factor and comorbid conditions distribution of CAP in adults in primary care in Spain. Methods: Retrospective observational study in adults (≥18 years-old) with CAP diagnosed and attended at primary care in Spain between 2009 and 2013, using the Computerized Database for Pharmacoepidemiological Studies in Primary Care (BIFAP). Results: Twenty-eight thousand four hundred thirteen patient records were retrieved and analyzed. Mean age (standard deviation): 60.5 (20.3) years, 51.7% males. Global incidence of CAP in adults was estimated at 4.63 per 1000 persons/year. CAP incidence increased progressively with age, ranging from a 1.98 at 18-20 years of age to 23.74 in patients over 90 years of age. According to sex, global CAP incidence was slightly higher in males (5.04) than females (4.26); CAP incidence from 18 to 65 year-olds up was comparable between males (range: 2.18-5.75) and females (range: 1.47-5.21), whereas from 65 years of age, CAP incidence was noticeable higher in males (range: 7.06-36.93) than in females (range: 5.43-19.62). Average prevalence of risk factors was 71.3%, which increased with age, doubling the risk in males by the age of 75 (females 20% vs males 40%). From 55 years of age, at least one risk factor was identified in 85.7% of cases: one risk factor (23.8%), two risk factors (23.4%), three or more risk factors (38.5%). Major risk factors were: metabolic disease (27.4%), cardiovascular disease (17.8%) and diabetes (15.5%). Conclusions: The annual incidence of CAP in primary care adults in Spain is high, comparable between males and females up to 65 years of age, but clearly increasing in males from that age. CAP risk increases with age and doubles in males older than 75 years. The majority of CAP cases in patients over 55 years of age is associated to at least one risk factor. The main risk factors associated were metabolic disease, cardiovascular disease, and diabetes. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
3. Incidence and risk factor prevalence of community-acquired pneumonia in adults in primary care in Spain (NEUMO-ES-RISK project).
- Author
-
Rivero-Calle, I, Pardo-Seco, J, Aldaz, P, Vargas, D A, Mascarós, E, Redondo, E, Díaz-Maroto, J L, Linares-Rufo, M, Fierro-Alacio, M J, Gil, A, Molina, J, Ocaña, D, Martinón-Torres, Federico, and NEUMOEXPERTOS group
- Subjects
- *
CARDIOVASCULAR diseases , *MEDICAL records , *METABOLIC disorders , *PNEUMONIA , *PRIMARY health care , *LIFESTYLES , *COMMUNITY-acquired infections , *DISEASE incidence , *DISEASE prevalence , *RETROSPECTIVE studies ,DEVELOPED countries - Abstract
Background: Community-acquired pneumonia (CAP) is a major cause of morbidity and mortality in adults even in developed countries. Several lifestyle factors and comorbidities have been linked to an increased risk, although their prevalence has not been well documented in the primary care setting. The aim of this study is to assess the incidence, risk factor and comorbid conditions distribution of CAP in adults in primary care in Spain.Methods: Retrospective observational study in adults (>18 years-old) with CAP diagnosed and attended at primary care in Spain between 2009 and 2013, using the Computerized Database for Pharmacoepidemiological Studies in Primary Care (BIFAP).Results: Twenty-eight thousand four hundred thirteen patient records were retrieved and analyzed. Mean age (standard deviation): 60.5 (20.3) years, 51.7 % males. Global incidence of CAP in adults was estimated at 4.63 per 1000 persons/year. CAP incidence increased progressively with age, ranging from a 1.98 at 18-20 years of age to 23.74 in patients over 90 years of age. According to sex, global CAP incidence was slightly higher in males (5.04) than females (4.26); CAP incidence from 18 to 65 year-olds up was comparable between males (range: 2.18-5.75) and females (range: 1.47-5.21), whereas from 65 years of age, CAP incidence was noticeable higher in males (range: 7.06-36.93) than in females (range: 5.43-19.62). Average prevalence of risk factors was 71.3 %, which increased with age, doubling the risk in males by the age of 75 (females 20 % vs males 40 %). From 55 years of age, at least one risk factor was identified in 85.7 % of cases: one risk factor (23.8 %), two risk factors (23.4 %), three or more risk factors (38.5 %). Major risk factors were: metabolic disease (27.4 %), cardiovascular disease (17.8 %) and diabetes (15.5 %).Conclusions: The annual incidence of CAP in primary care adults in Spain is high, comparable between males and females up to 65 years of age, but clearly increasing in males from that age. CAP risk increases with age and doubles in males older than 75 years. The majority of CAP cases in patients over 55 years of age is associated to at least one risk factor. The main risk factors associated were metabolic disease, cardiovascular disease, and diabetes. [ABSTRACT FROM AUTHOR]- Published
- 2016
4. Differences between diabetic and non-diabetic patients with community-acquired pneumonia in primary care in Spain.
- Author
-
Arias Fernández, Loreto, Pardo Seco, Jacobo, Cebey-López, Miriam, Gil Prieto, Ruth, Rivero-Calle, Irene, Martinon-Torres, Federico, Gil de Miguel, Ángel, Martinón-Torres, F., Vargas, D., Mascarós, E., Redondo, E., Díaz-Maroto, J. L., Linares-Rufo, M., Gil, A., Molina, J., Ocaña, D., Rivero-Calle, I., and NEUMOEXPERTOS group
- Subjects
- *
MEDICAL personnel , *COMMUNITY-acquired pneumonia , *PRIMARY care , *PARKINSON'S disease , *COMORBIDITY - Abstract
Background: Diabetes is one of the underlying risk factors for developing community-acquired pneumonia (CAP). The high prevalence of diabetes among population and the rising incidence of this illness, converts it as an important disease to better control and manage, to prevent its secondary consequences as CAP. The objective of this research is to describe the characteristics of the patients with diabetes and the differences with the no diabetes who have had an episode of CAP in the context of the primary care field.Methods: A retrospective, observational study in adult patients (> 18 years-old) who suffer from CAP and attended at primary care in Spain between 2009 and 2013 was developed using the Computerized Database for Pharmacoepidemiological Studies in Primary Care (BIFAP). We carried out a descriptive analysis of the first episodes of CAP, in patients with or without diabetes as comorbidity. Other morbidity (CVA, Anaemia, Arthritis, Asthma, Heart disease, Dementia, Depression, Dysphagia, Multiple sclerosis, Epilepsy, COPD, Liver disease, Arthrosis, Parkinson's disease, Kidney disease, HIV) and life-style factors were also included in the study.Results: A total of 51,185 patients were included in the study as they suffer from the first episode of CAP. Of these, 8012 had diabetes as comorbidity. There were differences between sex and age in patients with diabetes. Patients without diabetes were younger, and had less comorbidities including those related to lifestyles such as smoking, alcoholism, social and dental problems than patients with diabetes.Conclusions: Patients who developed an episode of CAP with diabetes have more risk factors which could be reduced with an appropriate intervention, including vaccination to prevent successive CAP episodes and hospitalization. The burden of associated factors in these patients can produce an accumulation of risk. Health care professional should know this for treating and control these patients in order to avoid complications. Diabetes and those other risk factors associated could be reduced with an appropriate intervention, including vaccination to prevent the first and successive CAP episodes and the subsequent hospitalization in severe cases. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
5. Impact of rotavirus vaccination on childhood hospitalizations for seizures: Heterologous or unforeseen direct vaccine effects?
- Author
-
Salas, A., Pardo-Seco, J., Cebey-López, M., Martinón-Martínez, J.M., Gómez-Rial, J., Currás-Tuala, M.J., Pischedda, S., Barral-Arca, R., Justicia-Grande, A., Rivero-Calle, I., Vilar, J., and Martinón-Torres, F.
- Subjects
- *
ROTAVIRUS vaccines , *ROTAVIRUSES , *TIME series analysis , *HOSPITAL care , *CHILDREN , *VACCINES - Abstract
• Decreased hospitalization rates by seizures for children <5 years old since RV vaccine introduction. • Stronger decrease of hospitalization rates by seizures with higher vaccination coverage. • Vaccination coverage impacts hospitalization rates 9 months after. There is a growing interest in the possible relationship between rotavirus (RV) vaccine and hospitalizations due to childhood seizures. We explored variation in hospitalization rates after 9 years of vaccination against pre-vaccination period for children <5 years of age from Galicia (Northwest Spain) before and after the introduction of the RV vaccines. Hospitalization rates for childhood seizures in Galician children were compared before and after RV vaccine introduction (in 2007) using different statistical approaches, including time series analyses. Our study cohort totaled 7,712 children <5 years of age admitted to hospital between 2002 and 2015 for "all kind of childhood seizures". Hospitalization rates decreases steadily with reductions ranging from 22.3% (95% CI: 15.0–29.1) in 2008, to 50.9% (95% CI: 45.5–55.7) in 2014, and significant results were also observed for <1, 1, and 2-year-old children in comparison with pre-vaccination period hospitalization rate. Regression models indicate a negative association between RV vaccination and hospitalizations for all kind of seizures. In addition, time series analyses are consistent with this finding and predict that vaccination coverage will affect hospitalization rates for "all kind of seizures" after 9 months. The results strongly support that RV vaccination has significantly reduced hospitalization rates due to childhood seizures. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
6. Salivary epidermal growth factor correlates with hospitalization length in rotavirus infection.
- Author
-
Gómez-Rial, J., Curras-Tuala, M. J., Talavero-González, C., Rodríguez-Tenreiro, C., Vilanova-Trillo, L., Gómez-Carballa, A., Rivero-Calle, I., Justicia-Grande, A., Pardo-Seco, J., Redondo-Collazo, L., Salas, A., and Martinón-Torres, F.
- Subjects
- *
SALIVARY gland physiology , *EPIDERMAL growth factor , *LENGTH of stay in hospitals , *ROTAVIRUS diseases , *INTERFERON genetics , *INTERFERON alpha , *BIOMARKERS - Abstract
Background: The IFI27 interferon gene expression has been found to be largely increased in rotavirus (RV)-infected patients. IFI27 gene encodes for a protein of unknown function, very recently linked to epidermal proliferation and related to the epidermal growth factor (EGF) protein. The EGF is a low-molecular-weight polypeptide that is mainly produced by submandibular and parotid glands, and it plays an important physiological role in the maintenance of oro-esophageal and gastric tissue integrity. Our aim was to determine salivary EGF levels in RV-infected patients in order to establish its potential relationship with IFI27 increased expression and EGF-mediated mucosal protection in RV infection.Methods: We conducted a prospective comparative study using saliva samples from 27 infants infected with RV (sampled at recruitment during hospital admission and at convalescence, i.e. at least 3 months after recovery) and from 36 healthy control children.Results: Median (SD) EGF salivary concentration was 777 (529) pg/ml in RV-infected group at acute phase and 356 (242) pg/m at convalescence, while it was 337 (119) pg/ml in the healthy control group. A significant association was found between EGF levels and hospitalization length of stay (P-value = 0.022; r2 = -0.63).Conclusions: The salivary levels of EGF are significantly increased during the acute phase of natural RV infection, and relate to length of hospitalization. Further assessment of this non-invasive biomarker in RV disease is warranted. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
7. Sex-biased expression of the TLR7 gene in severe COVID-19 patients: Insights from transcriptomics and epigenomics.
- Author
-
Gómez-Carballa, A., Pardo-Seco, J., Pischedda, S., Rivero-Calle, I., Butler-Laporte, G., Richards, J.B., Viz-Lasheras, S., Martinón-Torres, F., and Salas, A.
- Subjects
- *
COVID-19 , *GENOME-wide association studies , *GENE expression , *COVID-19 pandemic , *TOLL-like receptors , *GENETIC variation , *EPIGENOMICS - Abstract
There is abundant epidemiological data indicating that the incidence of severe cases of coronavirus disease (COVID-19) is significantly higher in males than females worldwide. Moreover, genetic variation at the X-chromosome linked TLR7 gene has been associated with COVID-19 severity. It has been suggested that the sex-biased incidence of COVID-19 might be related to the fact that TLR7 escapes X-chromosome inactivation during early embryogenesis in females, thus encoding a doble dose of its gene product compared to males. We analyzed TLR7 expression in two acute phase cohorts of COVID-19 patients that used two different technological platforms, one of them in a multi-tissue context including saliva, nasal, and blood samples, and a third cohort that included different post-infection timepoints of long-COVID-19 patients. We additionally explored methylation patterns of TLR7 using epigenomic data from an independent cohort of COVID-19 patients stratified by severity and sex. In line with genome-wide association studies, we provide supportive evidence indicating that TLR7 has altered CpG methylation patterns and it is consistently downregulated in males compared to females in the most severe cases of COVID-19. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.